Feb 22, 2021 @ 11:48
Kasalanan ni Persida! Drilon says vaccine delay due to drug maker fears they’ll be the next Dengvaxia
Senator Franklin Drilon said the sins of Public Attorney’s Office head Persida Acosta has made it harder for the Philippines to secure COVID-19 vaccines.
The abogado said drug makers are wary they will suffer the same fate as Sanofi and face mutiple charges for the alleged negative side effects of dengue vaccine Dengvaxia — only in the Philippines.
“There are statements made by Sec. Galvez that number one, we are the only country that an indemnity agreement is required and this is because of the dozens of cases filed by PAO chief Acosta,” Drilon said in an ANC interview.
It’s been a major stumbling block on top of the government’s inability to provide advance payments. Nobody wins in the Dengvaxia panic, which has also victimized health workers.
“These poor medical workers, because of this strategy adopted by Acosta, are now spending their own funds – I am not saying they are not liable – but it almost borders on harassment when you filed cases all over the place,” Drilon added.